Cart
sales@molnova.com
Home - Products - Others - Other Targets - N-(4-fluorophenyl)benzo[d]thiazol-2-amine

N-(4-fluorophenyl)benzo[d]thiazol-2-amine

CAS No. 348-45-8

N-(4-fluorophenyl)benzo[d]thiazol-2-amine( —— )

Catalog No. M28897 CAS No. 348-45-8

N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 44 In Stock
2MG 29 In Stock
5MG 48 In Stock
10MG 79 In Stock
25MG 166 In Stock
50MG 230 In Stock
100MG 334 In Stock
200MG 455 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine
  • Note
    Research use only, not for human use.
  • Brief Description
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
  • Description
    N-(4-fluorophenyl)benzo[d]thiazol-2-amine is a protein kinase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CYP17
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    348-45-8
  • Formula Weight
    244.29
  • Molecular Formula
    C13H9FN2S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (511.69 mM)
  • SMILES
    Fc1ccc(Nc2nc3ccccc3s2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang M, et al. Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors. Eur J Med Chem. 2017 May 26;132:157-172.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Nudiposide

    Nudiposide has significant neuroprotective activities against glutamate-injured neurotoxicity in HT22 cells.

  • Linzagolix

    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.

  • MC-Gly-Gly-Phe

    MC-Gly-Gly-Phe is a cleavable linker used for antibody-drug conjugates (ADC).

Sign In Join Free